Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines.
Bekker, A; Schaaf, H S; Draper, H R; van der Laan, L; Murray, S; Wiesner, L; Donald, P R; McIlleron, H M; Hesseling, A C.
Antimicrob Agents Chemother
; 60(4): 2171-9, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26810651
Pharmacokinetics of first-line tuberculosis drugs in Tanzanian patients.
Serum Levels of Antituberculosis Drugs and Their Effect on Tuberculosis Treatment Outcome.
Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi.
Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis.
Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus.
Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.
Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes.
Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania.